Dr. Laura Pedroza

Investment Manager

Dr. Laura Pedroza is an Investment Manager of our HTGF Life Science Team. Prior to that, she worked as a postdoc and obtained her promotion in protein biochemistry at the University of Duisburg-Essen. In addition to her promotion, she continued her education in business administration. During her studies in medical biology at the Universities of Duisburg-Essen and Albert-Ludwigs University Freiburg, she completed various internships and stays abroad in the USA (Boston) and worked as a research assistant at the Fraunhofer Institute for Solar Energy Systems (ISE).

Portfolio

Posts & mentions

BB_Mosanna
Press
11. April 2023

Mosanna Therapeutics Announces a Seed Extension Financing Round to Complete Preparations to Enter the Clinic with MOS-118 in Metabolic Obstructive Sleep Apnea

Company pursuing a highly differentiated small molecule MOS-118 in Metabolic Obstructive Sleep Apnea. New investors, Supermoon Capital and HTGF, join founding investor Forty51 Ventures to complete the Seed syndicate. Company will use the funds to file an IND in preparation for a proof of mechanism and proof of concept in the clinic. Basel, Switzerland, April 11, 2023 – Mosanna Therapeutics AG, a Swiss Biotech company today announced that Supermoon Capital, a US based ven
 
Press
6. October 2022

Real-Time Monitoring of Bioprocesses: IRUBIS closes EUR 2.8m seed round led by HTGF, Verve Ventures and Ventura BioMed Investors

Biotech startup IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene. Munich, 6 October 2022 – IRUBIS was founded in September 2017 by Lorenz Sykora, Alexander Geißler and Anja Müller with the goal to automate the process d
 

Events

Event
16. July 2024

Life Science Pitch Day 2024

HTGF, the Innovation and Start-up Center for Biotechnology (IZB), leaps by BAYER, Boehringer Ingelheim, and Medice are proud to present Life Science Pitch Day 2024 on 16 July in Munich. This year’s Pitch Day promises #lifesciences, #drugdevelopment and #drugdelivery startups the unique opportunity to present their innovative business ideas to renowned venture capitalists and investors in a beautiful ambiance. Early-stage start-ups can apply until 16 June 2024. Dr. Laura Pedroza, Investment